Scancell Holdings
Trending Articles
Related Content
Media
Collaboration to investigate T cell receptors for cancer treatment
Scancell the developer of novel immunotherapies for the treatment of cancer, has entered into a research collaboration with BioNTech for the potential development of innovative, T cell receptor based therapeutics for the treatment of cancer